Family Medicine · Columbus, OH
NPI
1356333785
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4677 E Main St
Columbus, OH, 43213
Phone (614) 575-6270
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
861 services
Medicare patients, 2024
182
Average age 71
Drug cost, 2024
$820K
11,968 prescriptions
Company payments, 2025
$459
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Debra A Grayson was code 99213 (office e&m - established), 324 times for 133 patients. In total Debra A Grayson billed 861 services in 30 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 324 | 133 | $48.32 | $16K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 109 | 109 | $122.14 | $13K |
| G0008 Administration of influenza virus vaccine | Office | 76 | 76 | $30.00 | $2,280 |
| 90662 Vaccine Product | Office | 68 | 67 | $80.29 | $5,460 |
| 83037 Blood Count | Office | 60 | 32 | $9.52 | $571 |
| 82962 Clinical Chemistry | Office | 57 | 33 | $3.21 | $183 |
| 99214 Office E&M - Established | Office | 29 | 21 | $89.71 | $2,602 |
| 81002 Clinical Chemistry | Office | 21 | 13 | $3.41 | $71.61 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 19 | 16 | $139.69 | $2,654 |
| 93000 Electrocardiogram | Office | 12 | 12 | $8.86 | $106 |
By year: 2022 $50K for 1,000 services; 2023 $52K for 1,022 services; 2024 $46K for 861 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83037 Blood Count | 60 | 32 | $9.52 | $571 |
| 82962 Clinical Chemistry | 57 | 33 | $3.21 | $183 |
| 81002 Clinical Chemistry | 21 | 13 | $3.41 | $71.61 |
Medicare prescription drug claims, 2024
In 2024, the drug Debra A Grayson prescribed most often to Medicare patients was Atorvastatin Calcium, with 507 prescriptions and refills. In total Debra A Grayson wrote 11,968 Medicare prescriptions that cost $820K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 507 | 1,345 | 123 | $6,788 |
| Losartan Potassium Generic | 429 | 1,005 | 95 | $4,349 |
| Amlodipine Besylate Generic | 411 | 1,023 | 99 | $1,739 |
| Levothyroxine Sodium Generic | 314 | 698 | 66 | $2,879 |
| Gabapentin Generic | 286 | 464 | 63 | $4,356 |
| Lisinopril Generic | 281 | 744 | 71 | $1,627 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 274 | 358 | 55 | $7,524 |
| Tramadol Hcl Generic | 250 | 250 | 43 | $1,540 |
| Omeprazole Generic | 246 | 610 | 64 | $3,006 |
| Furosemide Generic | 243 | 553 | 59 | $1,252 |
| Hydrochlorothiazide Generic | 241 | 554 | 54 | $486 |
| Rosuvastatin Calcium Generic | 241 | 596 | 61 | $6,707 |
| Metoprolol Succinate Generic | 216 | 471 | 50 | $3,331 |
| Trazodone Hcl Generic | 196 | 317 | 39 | $1,771 |
| Glipizide Generic | 192 | 483 | 44 | $1,796 |
Brand drugs: 1,270 claims; generic drugs: 10,582 claims; opioid claims: 746.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Debra A Grayson $459 ($459 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $209.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $209 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $58.14 |
| Pfizer Inc. PFE | 3 | $48.07 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $35.37 |
| Exact Sciences Corporation EXAS | 2 | $33.18 |
| Axsome Therapeutics, Inc. AXSM | 1 | $22.74 |
| Dexcom, Inc. DXCM | 1 | $18.29 |
| Lilly USA, LLC LLY | 1 | $17.85 |
| Aimmune Therapeutics, Inc. | 1 | $16.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.